GSK Potential Blockbuster Asthma Drug Shows Promise in Latest Trial -- Update

By Najat Kantouar and Helena Smolak


GSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential blockbuster sales of 3 billion pounds annually...

Related Keywords

United Kingdom ,British ,Najat Kantouar ,Helena Smolak ,Emma Walmsley , ,Chief Executive Emma Walmsley ,Dow Jones ,